Japan Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook

Name: Japan Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biologics contract development and manufacturing organization (cdmo) market in Japan is expected to reach a projected revenue of US$ 3,270.5 million by 2033. A compound annual growth rate of 8% is expected of Japan biologics contract development and manufacturing organization (cdmo) market from 2026 to 2033.

Japan biologics contract development and manufacturing organization (cdmo) product outlook (Revenue, USD million, 2021-2033)
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins & Enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic Acid Therapeutics
- Other Product
Japan biologics contract development and manufacturing organization (cdmo) service outlook (Revenue, USD million, 2021-2033)
- Packaging and Labelling
- Regulatory Affairs
- Logistics & Storage
- Other Service
- Contract Development
  - Cell Line Development
  - Analytical Testing & Method Validation
  - Scale-Up & Tech Transfer
  - Process Development
    - Upstream
    - Downstream
- Contract Manufacturing
  - API Manufacturing
  - Finished Drug Products Manufacturing
Japan biologics contract development and manufacturing organization (cdmo) source outlook (Revenue, USD million, 2021-2033)
- Mammalian
- Microbial
Japan biologics contract development and manufacturing organization (cdmo) workflow outlook (Revenue, USD million, 2021-2033)
- Commerical
- Clinical
Japan biologics contract development and manufacturing organization (cdmo) therapeutic area outlook (Revenue, USD million, 2021-2033)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Neurological Diseases
- Other Therapeutic Area
Japan biologics contract development and manufacturing organization (cdmo) end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- Other End Use

Japan Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook

Sign up - it's easy, and free!